🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Save the date pour les professionnels de santé: journée de formation sur la SEP progressive, organisée par la fédération neuro-SEP et les CRC SEP d'ile de France, le 28 mars 2024. Inscriptions: formationsneurosepidf.teamresa.net ANAINF @FondationARSEP @SFNeurologie F-CRIN

📢 New study: cost savings potential in treating Multiple Sclerosis (MS). If ocrelizumab was priced like its counterpart, rituximab, US tax payers would have saved $2.5 billion. 💸 #HealthcareEconomics #MSResearch #BigPharma Link: jamanetwork.com/journals/jaman…

L’etude BTKi avec evobrutinib est négative chez les patients avec SEP RR. Pas de différence par rapport au teriflunomide sur le risque de poussée. Evobrutinib Phase III | Merck merckgroup.com/en/news/evobru…

Une équipe de scientifiques de l'Institut du Cerveau - Paris Brain Institute, menée par la Pr. Céline Louapre, suggère que les mécanismes biologiques à l’origine de la sclérose en plaques soient enclenchés des années avant le diagnostic clinique. #ScléroseEnPlaques #SEP institutducerveau-icm.org/fr/actualite/s…

Check out our new study on prodromal (but also early stage) symptoms in #MS : not that specific to MS! Congratulation to Octave Guinebretiere and Thomas Nedelec from ARAMISLAB Stanley Durrleman at Institut du Cerveau - Paris Brain Institute for the hard work

📣Identification de 5 symptômes annonciateurs d’une maladie inflammatoire auto-immune telle que la #scleroseenplaques Lire le résumé de l'étude : 👉arsep.org/fr/actualites/…

Butzkueven et al. report that daily oral vitamin D3 supplements did not delay the conversion of high-risk clinically isolated syndrome to clinically definite MS. tinyurl.com/37dybb54

Important study from Céline Louapre 's group demonstrating that risk of severe #COVID19 in #multiplesclerosis has improved with vaccination but still remains elevated in patients with certain risk factors journals.sagepub.com/doi/full/10.11…

📣conférence #scléroseenplaques les espoirs de la recherche  Semaine du #cerveau ! 📅lundi 11 mars ⏰17h-19h15 - Céline Louapre, neurologue 🩺 - Brahim Naït-Oumesmar, directeur de recherche Inserm 🔬 ℹ️ et dès 17h, stands d'info sur la #SEP 👍 👇semaineducerveau.fr/manifestation/…

The Move Europe : le mime et le jeu de rôle au service de l'apprentissage des étudiants et étudiantes en #médecine. Sorbonne Université institutducerveau-icm.org/fr/actualite/t…

Retour en photos sur l'édition 2024 du tournoi international de #sémiologie neurologique pour les étudiant·es en médecine The Move Europe.

Thouvenot (Fr) D-Lay MS study with vitamin D (100k IU/14d) in CIS. Showing 34% risk reduction of new disease activity vs placebo! Proof of a safe and effective treatment in MS! Certainly in CIS and in patients with low vit D already! Use it as ADD-ON R/! 👏🏻👏🏻 #ECTRIMS2024

Great results of D-Lay MS trial in France coordinated by Pr Thouvenot from Nîmes University Hospital, presented at #ECTRIMS2024 ECTRIMS Vit D reduced disease activity in early MS F-CRIN

Thank you ECTRIMS for the great opportunity to present my work on deep sulcal inflammation in MS #PET #MRI

Thank you for the opportunity to present my PhD work about early energetic dysregulation in MS, during the ECTRIMS 2024 congress

Fantastic few days in Copenhagen for #ECTRIMS2024 🧠

🚨 Cues of trained immunity in macrophages of Multiple Sclerosis patients... Curious to know more? 🔍 Dive into our latest paper showcasing the fantastic work by Jennifer Fransson! 🧾✨ #MultipleSclerosis #TrainedImmunity #OpenAcess Institut du Cerveau - Paris Brain Institute neurology.org/doi/10.1212/NX…